The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Brain Atrophy in Type 2 Diabetes
Open accessAbstract
OBJECTIVE: Type 2 diabetes (T2DM) is associated with brain atrophy and cerebrovascular disease. We aimed to define the regional distribution of brain atrophy in T2DM and to examine whether atrophy or cerebrovascular lesions are feasible links between T2DM and cognitive function. RESEARCH DESIGN AND METHODS: This cross-sectional study used magnetic resonance imaging (MRI) scans and cognitive tests in 350 participants with T2DM and 363 participants without T2DM. With voxel-based morphometry, we studied the regional distribution of atrophy in T2DM. We measured cerebrovascular lesions (infarcts, microbleeds, and white matter hyperintensity [WMH] volume) and atrophy (gray matter, white matter, and hippocampal volumes) while blinded to T2DM status. With use of multivariable regression, we examined for mediation or effect modification of the association between T2DM and cognitive measures by MRI measures. RESULTS: T2DM was associated with more cerebral infarcts and lower total gray, white, and hippocampal volumes (all P < 0.05) but not with microbleeds or WMH. T2DM-related gray matter loss was distributed mainly in medial temporal, anterior cingulate, and medial frontal lobes, and white matter loss was distributed in frontal and temporal regions. T2DM was associated with poorer visuospatial construction, planning, visual memory, and speed (P ≤ 0.05) independent of age, sex, education, and vascular risk factors. The strength of these associations was attenuated by almost one-half when adjusted for hippocampal and total gray volumes but was unchanged by adjustment for cerebrovascular lesions or white matter volume. CONCLUSIONS: Cortical atrophy in T2DM resembles patterns seen in preclinical Alzheimer disease. Neurodegeneration rather than cerebrovascular lesions may play a key role in T2DM-related cognitive impairment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“A notable parallel is that a similar distribution of cortical atrophy was described in early Alzheimer disease in neuropathological studies (31) and a longitudinal MRI study (17), where gray matter loss began in the temporal, entorhinal, and parietal lobes before progressing to orbitofrontal regions and more so in the…”
Development and validation of a geriatric depression screening scale: a preliminary report
Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90033-4 · Cited by 15,025
Ashburner, J., & Friston, K. J. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.02.018 · Cited by 7,507
A global optimisation method for robust affine registration of brain images
Jenkinson, M., & Smith, S. (2001) · Medical Image Analysis · doi:10.1016/s1361-8415(01)00036-6 · Cited by 6,872
Automated Talairach Atlas labels for functional brain mapping
Lancaster, J. L., Woldorff, M. G., Parsons, L. M., Liotti, M., Freitas, C. S., Rainey, L., Kochunov, P. V., Nickerson, D., Mikiten, S. A., & Fox, P. T. (2000) · Human Brain Mapping · doi:10.1002/1097-0193(200007)10:3<120::aid-hbm30>3.0.co;2-8 · Cited by 3,387
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Neuropsychological assessment, 4th ed.
Lezak, M. D., Howieson, D. B., Loring, D. W., Hannay, H. J., & Fischer, J. S. (2004) · Cited by 1,934
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207
Dynamics of Gray Matter Loss in Alzheimer's Disease
Thompson, P. M., Hayashi, K. M., de Zubicaray, G., Janke, A. L., Rose, S. E., Semple, J., Herman, D., Hong, M. S., Dittmer, S. S., Doddrell, D. M., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00994.2003 · Cited by 1,132
Cordonnier, C., Al-Shahi Salman, R., & Wardlaw, J. (2007) · Brain · doi:10.1093/brain/awl387 · Cited by 703
Incidence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study
Vermeer, S. E., den Heijer, T., Koudstaal, P. J., Oudkerk, M., Hofman, A., & Breteler, M. M. B. (2003) · Stroke · doi:10.1161/01.str.0000052631.98405.15 · Cited by 680
Longstreth, W. T. (1998) · Archives of Neurology · doi:10.1001/archneur.55.9.1217 · Cited by 573
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease
Srikanth, V., Maczurek, A., Phan, T., Steele, M., Westcott, B., Juskiw, D., & Münch, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.016 · Cited by 524 · cited 1×
“Chronic hyperglycemia increases the formation of advanced glycation end products, which promote oxidative stress, cross-linking of amyloid fibrils, modification of cytoskeletal tau proteins, and inflammation (36).”
Self-citationType 2 diabetes and atrophy of medial temporal lobe structures on brain MRI
den Heijer, T., Vermeer, S. E., van Dijk, E. J., Prins, N. D., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2003) · Diabetologia · doi:10.1007/s00125-003-1235-0 · Cited by 514
Brain Magnetic Resonance Imaging Correlates of Impaired Cognition in Patients With Type 2 Diabetes
Manschot, S. M., Brands, A. M. A., van der Grond, J., Kessels, R. P. C., Algra, A., Kappelle, L. J., Biessels, G. J., & on behalf of the Utrecht Diabetic Encephalopathy Study Group (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1323 · Cited by 482
Brain Imaging in Patients With Diabetes
van Harten, B., de Leeuw, F.-E., Weinstein, H. C., Scheltens, P., & Biessels, G. J. (2006) · Diabetes Care · doi:10.2337/dc06-1637 · Cited by 350
Magnetic Resonance Imaging of the Brain in Diabetes
Schmidt, R., Launer, L. J., Nilsson, L.-G., Pajak, A., Sans, S., Berger, K., Breteler, M. M., de Ridder, M., Dufouil, C., Fuhrer, R., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.3.687 · Cited by 249
Insulin Resistance, Brain Atrophy, and Cognitive Performance in Late Middle–Aged Adults
Willette, A. A., Xu, G., Johnson, S. C., Birdsill, A. C., Jonaitis, E. M., Sager, M. A., Hermann, B. P., La Rue, A., Asthana, S., & Bendlin, B. B. (2013) · Diabetes Care · doi:10.2337/dc12-0922 · Cited by 219
Progression of brain atrophy and cognitive decline in diabetes mellitus: A 3-year follow-up
van Elderen, S. G. C., de Roos, A., de Craen, A. J. M., Westendorp, R. G. J., Blauw, G. J., Jukema, J. W., Bollen, E. L. E. M., Middelkoop, H. A. M., van Buchem, M. A., & van der Grond, J. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f25f06 · Cited by 207
Type 2 diabetes and risk of cognitive impairment and dementia
Whitmer, R. A. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0058-7 · Cited by 197
Correia, S. C., Santos, R. X., Carvalho, C., Cardoso, S., Candeias, E., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2012) · Brain Research · doi:10.1016/j.brainres.2011.12.063 · Cited by 195
An update on type 2 diabetes, vascular dementia and Alzheimer’s disease.
Exalto, L. G., Whitmer, R. A., Kappele, L. J., & Biessels, G. J. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.07.014 · Cited by 194 · cited 1×
“The mechanisms underlying brain atrophy in T2DM may include endocrine, metabolic, and vascular pathways (35).”
Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus
van Harten, B., Oosterman, J., Muslimovic, D., van Loon, B.-J. P., Scheltens, P., & Weinstein, H. C. (2007) · Age and Ageing · doi:10.1093/ageing/afl180 · Cited by 171
Insulin resistance and pathological brain ageing
Cholerton, B., Baker, L. D., & Craft, S. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03464.x · Cited by 160
Cerebral Small Vessel Disease: A Review of Clinical, Radiological, and Histopathological Phenotypes
Moran, C., Phan, T. G., & Srikanth, V. K. (2011) · International Journal of Stroke · doi:10.1111/j.1747-4949.2011.00725.x · Cited by 150
Self-citationAutomated measurement of brain and white matter lesion volume in type 2 diabetes mellitus
Jongen, C., van der Grond, J., Kappelle, L. J., Biessels, G. J., Viergever, M. A., Pluim, J. P. W., & on behalf of the Utrecht Diabetic Encephalopathy Study Group (2007) · Diabetologia · doi:10.1007/s00125-007-0688-y · Cited by 150
Cerebral cortical thickness in patients with type 2 diabetes
Brundel, M., van den Heuvel, M. P., de Bresser, J., Kappelle, L. J., & Biessels, G. J. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.048 · Cited by 139
Mapping the brain in type II diabetes: Voxel-based morphometry using DARTEL
Chen, Z., Li, C., Sun, J., & Ma, L. (2011) · European Journal of Radiology · doi:10.1016/j.ejrad.2011.04.025 · Cited by 98
Retinal and Cerebral Microvascular Signs and Diabetes
Qiu, C., Cotch, M. F., Sigurdsson, S. O., Garcia, M., Klein, R., Jónasson, F., Klein, B. E. K., Eiríksdóttir, G., Harris, T. B., van Buchem, M. A., et al. (2008) · Diabetes · doi:10.2337/db07-1455 · Cited by 98
Methylglyoxal, Cognitive Function and Cerebral Atrophy in Older People
Srikanth, V. K., Westcott, B., Forbes, J. M., Phan, T. G., Beare, R. J., Venn, A., Pearson, S., Greenaway, T. M., Parameswaran, V., & Münch, G. W. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls100 · Cited by 98
Self-citationHayashi, K., Kurioka, S., Yamaguchi, T., Morita, M., Kanazawa, I., Takase, H., Wada, A., Kitagaki, H., Nagai, A., Bokura, H., et al. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.07.002 · Cited by 85
Streifler, J. Y., Eliasziw, M., Benavente, O., Alamowitch, S., Fox, A. J., Hachinski, V., & Barnett, H. J. M. (2003) · Stroke · doi:10.1161/01.str.0000080939.39414.83 · Cited by 80
Lazarus, R., Prettyman, R. J., & Cherryman, G. R. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1283 · Cited by 73
Kumar, R., Anstey, K. J., Cherbuin, N., Wen, W. X., & Sachdev, P. S. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31818b40fc · Cited by 70
Hippocampal volume and depression: insights from epilepsy surgery
Wrench, J. M., Wilson, S. J., Bladin, P. F., & Reutens, D. C. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.152165 · Cited by 50
Kamiyama, K., Wada, A., SUGIHARA, M., Kurioka, S., Hayashi, K., Hayashi, T., Yoshisako, T., Yamamoto, N., Tsuchie, Y., Yamaguchi, S., et al. (2010) · Japanese Journal of Radiology · doi:10.1007/s11604-009-0416-2 · Cited by 46
Beare, R. J., Srikanth, V. K., Chen, J., Phan, T. G., Stapleton, J., Lipshut, R., & Reutens, D. C. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.03.055 · Cited by 44
Self-citation
Cited by
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723
Hippocampal insulin resistance and cognitive dysfunction
Biessels, G. J., & Reagan, L. P. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4019 · Cited by 537
Impact of diabetes on cognitive function and brain structure
Moheet, A., Mangia, S., & Seaquist, E. R. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12807 · Cited by 510
Verdile, G., Keane, K. N., Cruzat, V. F., Medic, S., Sabale, M., Rowles, J., Wijesekara, N., Martins, R. N., Fraser, P. E., & Newsholme, P. (2015) · Mediators of Inflammation · doi:10.1155/2015/105828 · Cited by 495
Type 2 diabetes and cognitive dysfunction–towards effective management of both comorbidities
Srikanth, V., Sinclair, A. J., Hill-Briggs, F., Moran, C., & Biessels, G. J. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30118-2 · Cited by 465
Self-citation
Metadata
- Authors
- Moran, C., Phan, T. G., Chen, J., Blizzard, L., Beare, R., Venn, A., Münch, G., Wood, A. G., Forbes, J., Greenaway, T. M., Pearson, S., & Srikanth, V.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-11-13
- Volume
- 36
- Issue
- 12
- Pages
- 4036-4042
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2141866284
- Cited by
- 517
- References
- 38
- FWCI
- 25.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.